$6.35B
$10,000
0.0% of portfolio
86
Q2 2024
Added 13.16%
$0
$1,000
0.0% of portfolio
43
Q4 2022
Reduced 90.57%
$0
$15,000
0.0% of portfolio
704
Q4 2022
Reduced 44.74%
$9.08B
$5,000
0.0% of portfolio
80
Q1 2024
New
$3.96B
$17,000
0.0% of portfolio
210
Q2 2024
Reduced 5.83%
Skyward Specialty Insurance Group Inc
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 5.11%
$6.82B
$15,000
0.0% of portfolio
348
Q1 2024
Reduced 40.41%
$14.9B
$41,000
0.0% of portfolio
157
Q2 2024
Reduced 20.71%
-
$0
0.0% of portfolio
-
Q4 2022
New
$10.9B
$5,000
0.0% of portfolio
131
Q4 2023
Reduced 57.47%
$843M
$9,000
0.0% of portfolio
619
Q2 2022
New
-
$0
0.0% of portfolio
-
Q2 2024
New
$5.37B
$32,000
0.0% of portfolio
644
Q2 2024
Reduced 6.4%
$7.18B
$7,000
0.0% of portfolio
99
Q2 2024
Added 8.79%
$76.3B
$32,000
0.0% of portfolio
303
Q2 2024
New
$6.9B
$2,000
0.0% of portfolio
310
Q3 2023
New
$3.48B
$30,000
0.0% of portfolio
506
Q3 2022
New
$2.34B
$3,000
0.0% of portfolio
100
Q1 2024
New
$11B
$20,000
0.0% of portfolio
251
Q2 2024
Reduced 16.05%
$6.25B
$14,000
0.0% of portfolio
776
Q2 2024
Reduced 95.1%
$17.2B
$4,000
0.0% of portfolio
46
Q2 2024
New
$2.06B
$7,000
0.0% of portfolio
120
Q2 2024
Added 7.14%
$9.11B
$8,000
0.0% of portfolio
99
Q2 2024
Added 43.48%
$335M
$4,000
0.0% of portfolio
1,000
Q2 2024
New
$26.1B
$26,000
0.0% of portfolio
685
Q2 2024
Added 0.88%
$3.55B
$8,000
0.0% of portfolio
119
Q2 2024
Reduced 8.46%
Structure Therapeutics Inc
-
$0
0.0% of portfolio
-
Q1 2024
Added 238.1%
$4.46B
$28,000
0.0% of portfolio
768
Q1 2024
Added 239.82%
$18.3B
$4,000
0.0% of portfolio
35
Q1 2024
Reduced 20.45%
$32.9B
$9,000
0.0% of portfolio
184
Q2 2024
Added 1.1%
$49.7B
$43,000
0.0% of portfolio
1,135
Q1 2024
Reduced 9.56%
$4.49B
$36,000
0.0% of portfolio
650
Q1 2024
Reduced 23.53%
$4.08B
$2,000
0.0% of portfolio
200
Q1 2023
New
$2.16B
$5,000
0.0% of portfolio
495
Q4 2023
Added 17.02%
$1.66B
$3,000
0.0% of portfolio
128
Q4 2023
Reduced 55.56%
$3.39B
$17,000
0.0% of portfolio
252
Q2 2024
Reduced 29.81%
$6.49B
$8,000
0.0% of portfolio
211
Q2 2022
New
$10.8B
$4,000
0.0% of portfolio
39
Q1 2024
Reduced 36.07%
$3.69B
$6,000
0.0% of portfolio
502
Q2 2022
New
$12.5B
$17,000
0.0% of portfolio
122
Q2 2024
Added 0.83%
-
$0
0.0% of portfolio
-
Q1 2024
Added 75.0%
$4.5B
$2,000
0.0% of portfolio
60
Q2 2024
New
T. Rowe Price Exchangetraded Funds Inc
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 13.13%
$45.7B
$5,000
0.0% of portfolio
437
Q1 2024
Reduced 9.34%
$2.82B
$12,000
0.0% of portfolio
309
Q2 2024
Added 128.89%
$10.4B
$21,000
0.0% of portfolio
510
Q2 2024
Reduced 32.63%
$33.6B
$32,000
0.0% of portfolio
250
Q1 2024
Reduced 4.94%
$7.44B
$13,000
0.0% of portfolio
237
Q3 2023
Reduced 2.07%
$24.2B
$41,000
0.0% of portfolio
870
Q4 2023
Reduced 24.35%
$1.31B
$8,000
0.0% of portfolio
892
Q2 2024
Added 79.12%